CERTARA INC. - COMMON

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  

21 Nov 2023 15:30:00 By Nasdaq GlobeNewswire

Certara Reports Third Quarter 2023 Financial Results

08 Nov 2023 15:10:01 By Nasdaq GlobeNewswire

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

11 Oct 2023 15:15:00 By Nasdaq GlobeNewswire

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

19 Sep 2023 07:15:00 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

29 Aug 2023 15:15:00 By Nasdaq GlobeNewswire

Certara Simcyp™ Group Awarded Two New Grants from US FDA

29 Aug 2023 07:15:00 By Nasdaq GlobeNewswire

Certara Reports Second Quarter 2023 Financial Results

09 Aug 2023 15:15:01 By Nasdaq GlobeNewswire

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

13 Jul 2023 15:30:00 By Nasdaq GlobeNewswire

Certara to Participate in the Jefferies Global Healthcare Conference

02 Jun 2023 15:15:00 By Nasdaq GlobeNewswire

Certara Reports First Quarter 2023 Financial Results

08 May 2023 15:15:00 By Nasdaq GlobeNewswire

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year

27 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference

10 Apr 2023 15:30:00 By Nasdaq GlobeNewswire

A.I. Coming to Certara’s D360 Scientific Informatics Software

09 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

07 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Certara Reports Fourth Quarter and Full Year 2022 Financial Results

01 Mar 2023 15:16:01 By Nasdaq GlobeNewswire

Certara Announces Transition Plan for Chief Financial Officer

01 Mar 2023 15:15:00 By Nasdaq GlobeNewswire

Certara to Participate in the Barclays Global Healthcare Conference

27 Feb 2023 15:30:00 By Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023

01 Feb 2023 15:30:00 By Nasdaq GlobeNewswire

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

04 Jan 2023 06:31:24 By Nasdaq GlobeNewswire

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

08 Dec 2022 15:30:00 By Nasdaq GlobeNewswire